Jun 26, 2025, 13:45
Dr Sthanu Subramanian: Tenecteplase VS Alteplase – TNK Targets the Fibrin in Blood Clots More Effectively
Dr. Sthanu Subramanian shared a post on X:
“Tenecteplase (TNK) vs. Alteplase (tPA):
TNK targets the fibrin in blood clots more effectively.
This means it is less likely to activate the body’s natural clotting system elsewhere, potentially reducing the risk of bleeding complications.”
Read also Dr Sthanu Subramanian Highlights EMS Protocols for Managing Atrial Fibrillation.
-
May 28, 2026, 09:16Maxime Dely: The Human Connection Behind Stem Cell Donation
-
May 28, 2026, 09:15Heghine Khachatryan: Maternal Health Begins With Recognizing Iron Deficiency Early
-
May 28, 2026, 09:15Alejandro González Veliz: Why Cardiovascular Prevention Matters More Than Intervention
-
May 28, 2026, 05:29Kidist K.: First Balloon Pulmonary Angioplasty Performed as New CTEPH Program Launches
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires